Managing Osteoporosis and Joint Damage in Patients with Rheumatoid Arthritis: An Overview
出版年份 2021 全文链接
标题
Managing Osteoporosis and Joint Damage in Patients with Rheumatoid Arthritis: An Overview
作者
关键词
-
出版物
Journal of Clinical Medicine
Volume 10, Issue 6, Pages 1241
出版商
MDPI AG
发表日期
2021-03-17
DOI
10.3390/jcm10061241
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
- (2020) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Views on glucocorticoid therapy in rheumatology: the age of convergence
- (2020) Frank Buttgereit Nature Reviews Rheumatology
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS—2020 UPDATE
- (2020) Pauline M. Camacho et al. Endocrine Practice
- Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention
- (2020) Hennie G Raterman et al. EXPERT OPINION ON PHARMACOTHERAPY
- Human dendritic cell-derived osteoclasts with high bone resorption capacity and T cell stimulation ability
- (2020) Manabu Narisawa et al. BONE
- RANKL as a therapeutic target of rheumatoid arthritis
- (2020) Sakae Tanaka et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Osteoporosis
- (2019) Juliet E Compston et al. LANCET
- Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial
- (2019) Tsutomu Takeuchi et al. ANNALS OF THE RHEUMATIC DISEASES
- Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study
- (2019) Josef S Smolen et al. LANCET
- Osteoporosis in Rheumatic Diseases: Anti-rheumatic Drugs and the Skeleton
- (2018) Alanna M. Dubrovsky et al. CALCIFIED TISSUE INTERNATIONAL
- Mechanisms and therapeutic targets for bone damage in rheumatoid arthritis, in particular the RANK-RANKL system
- (2018) Yoshiya Tanaka et al. CURRENT OPINION IN PHARMACOLOGY
- Therapeutic Mechanisms of Glucocorticoids
- (2018) Jolien Vandewalle et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Trends and Determinants of Osteoporosis Treatment and Screening in Patients With Rheumatoid Arthritis Compared to Osteoarthritis
- (2018) Gulsen Ozen et al. ARTHRITIS CARE & RESEARCH
- Rheumatoid arthritis
- (2018) Josef S. Smolen et al. Nature Reviews Disease Primers
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- Clinical immunity in bone and joints
- (2018) Yoshiya Tanaka JOURNAL OF BONE AND MINERAL METABOLISM
- Glucocorticoid-Induced Osteoporosis
- (2018) Lenore Buckley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathogenetic insights from the treatment of rheumatoid arthritis
- (2017) Iain B McInnes et al. LANCET
- RANKL: A therapeutic target for bone destruction in rheumatoid arthritis
- (2017) Sakae Tanaka et al. Modern Rheumatology
- Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
- (2017) Peter C. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
- (2017) Lenore Buckley et al. Arthritis & Rheumatology
- Osteoporosis treatment: recent developments and ongoing challenges
- (2017) Sundeep Khosla et al. Lancet Diabetes & Endocrinology
- 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
- (2017) Henry G Bone et al. Lancet Diabetes & Endocrinology
- Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis
- (2016) Shingo Nakayamada et al. BIODRUGS
- Rheumatoid arthritis
- (2016) Josef S Smolen et al. LANCET
- Association of the multi-biomarker disease activity score with joint destruction in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha inhibitor treatment in clinical practice
- (2016) Shintaro Hirata et al. Modern Rheumatology
- Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis
- (2016) Anca I. Catrina et al. Nature Reviews Rheumatology
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis
- (2016) Felicia Cosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Postmenopausal Osteoporosis
- (2016) Dennis M. Black et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Actions of Glucocorticoids in Cartilage and Bone During Health, Disease, and Steroid Therapy
- (2016) Kerstin Hartmann et al. PHYSIOLOGICAL REVIEWS
- Glucocorticoid-induced Osteoporosis
- (2016) Xena Whittier et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Postmenopausal osteoporosis
- (2016) Richard Eastell et al. Nature Reviews Disease Primers
- Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients withRheumatoId arthritis on methotrexate toValidate inhibitory effect on boneErosion (DRIVE)—a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial
- (2015) Tsutomu Takeuchi et al. ANNALS OF THE RHEUMATIC DISEASES
- Analysis of bone metabolism during early stage and clinical benefits of early intervention with alendronate in patients with systemic rheumatic diseases treated with high-dose glucocorticoid: Early DIagnosis and Treatment of OsteopoRosis in Japan (EDITOR-J) study
- (2015) Yoshiya Tanaka et al. JOURNAL OF BONE AND MINERAL METABOLISM
- A look behind the scenes: the risk and pathogenesis of primary osteoporosis
- (2015) Gretl Hendrickx et al. Nature Reviews Rheumatology
- Meta-Analysis of Tumor Necrosis Factor Inhibitors and Glucocorticoids on Bone Density in Rheumatoid Arthritis and Ankylosing Spondylitis Trials
- (2015) Stephanie Siu et al. ARTHRITIS CARE & RESEARCH
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osteitis and synovitis, but not bone erosion, is associated with proteoglycan loss and microstructure damage in the cartilage of patients with rheumatoid arthritis
- (2013) Barbara Herz et al. ANNALS OF THE RHEUMATIC DISEASES
- Janus kinase inhibitors in autoimmune diseases
- (2013) John J O'Shea et al. ANNALS OF THE RHEUMATIC DISEASES
- Differing effects of denosumab and alendronate on cortical and trabecular bone
- (2013) Roger M. Zebaze et al. BONE
- Arthritis and bone loss
- (2013) Arnd Kleyer et al. CURRENT OPINION IN RHEUMATOLOGY
- In vitro and in vivo analysis of a JAK inhibitor in rheumatoid arthritis
- (2012) Y Tanaka et al. ANNALS OF THE RHEUMATIC DISEASES
- Inflammatory bone loss: pathogenesis and therapeutic intervention
- (2012) Kurt Redlich et al. NATURE REVIEWS DRUG DISCOVERY
- Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment
- (2012) Georg Schett et al. Nature Reviews Rheumatology
- American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
- (2011) D. T. Felson et al. ANNALS OF THE RHEUMATIC DISEASES
- The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-γ and interleukin-17 production by human CD4+ T cells
- (2011) Keisuke Maeshima et al. ARTHRITIS AND RHEUMATISM
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- From bone biology to clinical outcome: state of the art and future perspectives
- (2010) G. Schett et al. ANNALS OF THE RHEUMATIC DISEASES
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) Daniel Aletaha et al. ARTHRITIS AND RHEUMATISM
- Denosumab and bisphosphonates: Different mechanisms of action and effects
- (2010) Roland Baron et al. BONE
- Osteoimmunology and the effects of the immune system on bone
- (2009) Hiroshi Takayanagi Nature Reviews Rheumatology
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now